Clifford Capital Partners’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.3M Buy
37,099
+10,226
+38% +$4.3M 2.38% 25
2026
Q1
$10.2M Sell
26,873
-19,599
-42% -$8.39M 1.69% 31
2025
Q4
$19.9M Sell
46,472
-518
-1% -$226K 3.38% 14
2025
Q3
$21M Buy
46,990
+46,196
+5,818% +$20.9M 3.64% 10
2025
Q2
$387K Buy
794
+202
+34% +$115K 0.07% 36
2025
Q1
$364K Buy
+592
New +$336K 0.07% 37

Other funds holding CHE

Clifford Capital Partners's CHE Position: Q2 2026 in Review

Clifford Capital Partners increased its Chemed (CHE) stake by 38% in Q2 2026, buying an estimated $4.3M and bringing the position to 37,099 shares worth $17.3M. The position accounts for 2.38% of the portfolio, ranked #25.

Clifford Capital Partners first reported a position in CHE in Q1 2025 and has held it in 6 quarters since. The position peaked at $21M in Q3 2025. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Clifford Capital Partners held 37,099 shares of Chemed worth $17.3M as of Q2 2026.
  • Clifford Capital Partners bought 10,226 Chemed shares in Q2 2026, an estimated $4.3M.
  • Chemed made up 2.38% of Clifford Capital Partners's portfolio in Q2 2026, its #25 holding.
  • Clifford Capital Partners first reported a position in Chemed in Q1 2025 and has held it in 6 quarters since.
  • Clifford Capital Partners's Chemed position peaked at $21M in Q3 2025.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Clifford Capital Partners's 13F filing for Q2 2026, filed 10 Aug 2026.